The BioInsights Podcast
The BioInsights Podcast: discussing the challenges of translating novel biologics from bench to clinic to market.
Podcasting since 2022 • 59 episodes
The BioInsights Podcast
Latest Episodes
Crossing the ADC inflection points: what separates clinical success from failure
Lauren Coyle, Launch Commissioning Editor, Bioconjugate Insights, speaks with Antoine Yver, Board Chair, Ona Therapeutics, with more than three and a half decades of experience shaping global cancer drug development. In this conversati...
•
Season 5
•
Episode 1
•
30:06
Formulation and delivery of RNA-based vaccines and therapeutics: addressing outstanding questions around safety and purity
In this interview, Róisin McGuigan, Editor, Nucleic Acid Insights, and Jesse Erasmus, Director of Virology at HDT Bio, discuss current challenges and opportunities in RNA safety, manufacturing, and targeted delivery, and ...
•
Season 4
•
Episode 8
•
24:22
Advancing nucleic acid therapeutics with circular RNA
In this podcast episode, Jokūbas Leikauskas, Editor, BioInsights, speaks to Trevor Hallam, who served as Chief Scientific Officer of Sail Biomedicines until July 2025. The interview, recorded in June 2025, explores advances in RNA...
•
Season 4
•
Episode 7
•
33:47
Exploring advances in bioconjugation: nanozymes, tissue tropism, and the future of responsive systems
Lauren Coyle (Commissioning Editor, Bioconjugation Insights) speaks to Vincent Rotello (Distinguished Professor of Chemistry, University of Massachusetts Amherst) about the advantages and limitations of different nanomate...
•
Season 4
•
Episode 6
•
15:29
The promise of antibody-oligonucleotide conjugates for neurological diseases
Lauren Coyle, Launch Commissioning Editor, Bioconjugation Insights, speaks with Kerstin Hofer, Science and People Lead, Roche, about the evolving application of antibody-oligonucleotide conjugates in neurology. She highli...
•
Season 4
•
Episode 5
•
21:22